Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention. (9th February 2016)

• Record Type: Journal Article
• Authors: Reed, S.M.; Furr, M.; Howe, D.K.; Johnson, A.L.; MacKay, R.J.; Morrow, J.K.; Pusterla, N.; Witonsky, S.
• Is Part Of: Journal of veterinary internal medicine. Volume 30:Number 2(2016:Mar./Apr.)
• Page Start: 491
• Page End: 502
• Publication Date: 2016-02-09
• Subjects: Encephalitis -- Equine myeloencephalopathy -- Equine neurologic -- Equine protozoal disease -- Myelitis -- Neospora hughesi -- Sarcocystis neurona; Veterinary medicine -- Periodicals; 636.0896
• DOI: 10.1111/jvim.13834
• Languages: English
• ISSNs: 0891-6640

Abstract

Abstract : Equine protozoal myeloencephalitis (EPM) remains an important neurologic disease of horses. There are no pathognomonic clinical signs for the disease. Affected horses can have focal or multifocal central nervous system (CNS) disease. EPM can be difficult to diagnose antemortem. It is caused by either of 2 parasites, Sarcocystis neurona and Neospora hughesi, with much less known about N. hughesi . Although risk factors such as transport stress and breed and age correlations have been identified, biologic factors such as genetic predispositions of individual animals, and parasite‐specific factors such as strain differences in virulence, remain largely undetermined. This consensus statement update presents current published knowledge of the parasite biology, host immune response, disease pathogenesis, epidemiology, and risk factors. Importantly, the statement provides recommendations for EPM diagnosis, treatment, and prevention.